Application of 3D-ASL in hemodynamic analysis and prognosis evaluation of vascular cognitive impairment

Jianguo Zhou1, Jiangtao He2, Wei Wang3

  • 1Department of Radiology, Lianyungang Hospital of Traditional Chinese Medicine Lianyungang 222004, Jiangsu, China.

Insights

Magnetic resonance 3D arterial spin labeling (3D-ASL) can assess cerebral hemodynamics in vascular cognitive impairment (VCI). Different post label delays (PLDs) offer varying sensitivity and accuracy for detecting hypoperfusion, aiding treatment decisions.

Area of Science:

  • Neuroimaging
  • Vascular Neurology
  • Cognitive Neuroscience

Background:

  • Vascular cognitive impairment (VCI) poses a significant health challenge.
  • Accurate hemodynamic analysis and prognostic assessment are crucial for VCI management.
  • 3D-ASL is a non-invasive neuroimaging technique with potential for VCI evaluation.

Purpose of the Study:

  • To evaluate the utility of 3D-ASL in hemodynamic analysis of VCI.
  • To assess the prognostic value of 3D-ASL in VCI patients.
  • To compare the effectiveness of different post label delays (PLDs) in 3D-ASL for VCI.

Main Methods:

  • Retrospective study of 108 ischemic cerebrovascular disease patients.
  • Cognitive function assessed using the Montreal Cognitive Assessment (MoCA).
  • 3D-ASL cerebral perfusion imaging performed with PLDs of 1525 ms and 2525 ms.
  • Cerebral blood flow (CBF) values analyzed in various brain regions.
  • Receiver operating characteristic (ROC) curve analysis for diagnostic accuracy.

Main Results:

  • VCI patients exhibited significantly reduced CBF in multiple brain regions compared to controls (P<0.05).
  • VCI group showed significantly lower MoCA scores across all domains (P<0.05).
  • ROC analysis indicated that PLD 2525 ms provided a more accurate hypoperfusion range than PLD 1525 ms (P<0.05).

Conclusions:

  • Non-invasive 3D-ASL is effective for analyzing cerebral hemodynamics in VCI.
  • 3D-ASL can aid in the prognostic assessment of VCI patients.
  • PLD 1525 ms is more sensitive for detecting hypoperfusion, while PLD 2525 ms offers a more precise range, guiding treatment adjustments.
Abstract